Henry Schein names new CEO
By HME News Staff
Updated 10:25 AM CST, Mon January 12, 2026
MELVILLE, N.Y. - Henry Schein has named Frederick M. Lowery as its new CEO effective March 2, 2026. He will also join the company’s board of directors at that time. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years but will continue to serve as chairman of the board to ensure a smooth and effective leadership transition. Lowery brings more than two decades of health care expertise to Henry Schein, with a strong track record of scaling complex businesses to drive significant growth and sustained value creation. Most recently, he served as executive vice president and president, Laboratory Products and BioProduction, at Thermo Fisher Scientific. “I am honored to join Henry Schein at such a pivotal moment,” Lowery said. “This is an organization with immense potential to impact clinicians and patients, given its remarkable reputation for innovation, customer service, and partnership. I look forward to working with Team Schein to build on the strong foundation established by Stan while accelerating value creation.” Prior to joining Thermo Fisher, Lowery worked in leadership roles for Maytag Corporation and General Motors. He holds a master’s degree in manufacturing management from Kettering University (formerly General Motors Institute of Engineering and Management) and a bachelor’s degree in mechanical engineering from Tennessee Technological University.
Comments